| A selective inhibitor of the p110δ isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16 C Billottet, VL Grandage, RE Gale, A Quattropani, C Rommel, ... Oncogene 25 (50), 6648-6659, 2006 | 219 | 2006 |
| CXCR3, a double-edged sword in tumor progression and angiogenesis C Billottet, C Quemener, A Bikfalvi Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (2), 287-295, 2013 | 180 | 2013 |
| TGFβ-induced endothelial podosomes mediate basement membrane collagen degradation in arterial vessels P Rottiers, F Saltel, T Daubon, B Chaigne-Delalande, V Tridon, C Billottet, ... Journal of cell science 122 (23), 4311-4318, 2009 | 108 | 2009 |
| Physiological type I collagen organization induces the formation of a novel class of linear invadosomes A Juin, C Billottet, V Moreau, O Destaing, C Albiges-Rizo, J Rosenbaum, ... Molecular biology of the cell 23 (2), 297-309, 2012 | 99 | 2012 |
| Modulation of several waves of gene expression during FGF‐1 induced epithelial‐mesenchymal transition of carcinoma cells C Billottet, M Tuefferd, D Gentien, A Rapinat, JP Thiery, P Broët, ... Journal of cellular biochemistry 104 (3), 826-839, 2008 | 87 | 2008 |
| Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation C Billottet, L Banerjee, B Vanhaesebroeck, A Khwaja Cancer research 69 (3), 1027-1036, 2009 | 84 | 2009 |
| The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment A Bikfalvi, C Billottet American Journal of Physiology-Cell Physiology 318 (3), C542-C554, 2020 | 66 | 2020 |
| The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors K Boyé, N Pujol, I D Alves, YP Chen, T Daubon, YZ Lee, S Dedieu, ... Nature Communications 8 (1), 1571, 2017 | 60 | 2017 |
| Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells C Billottet, N Elkhatib, JP Thiery, J Jouanneau Molecular biology of the cell 15 (10), 4725-4734, 2004 | 55 | 2004 |
| Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2 C Billottet, B Janji, JP Thiery, J Jouanneau Oncogene 21 (53), 8128-8139, 2002 | 53 | 2002 |
| Dual roles for CXCL4 chemokines and CXCR3 in angiogenesis and invasion of pancreatic cancer C Quemener, J Baud, K Boyé, A Dubrac, C Billottet, F Soulet, F Darlot, ... Cancer research 76 (22), 6507-6519, 2016 | 37 | 2016 |
| Regulatory signals for endothelial podosome formation C Billottet, P Rottiers, F Tatin, C Varon, E Reuzeau, JL Maître, F Saltel, ... European journal of cell biology 87 (8-9), 543-554, 2008 | 34 | 2008 |
| Tumor-stroma interactions C Billottet, J Jouanneau Bulletin du cancer 95 (1), 51-56, 2008 | 24 | 2008 |
| Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR) K Boye, C Billottet, N Pujol, ID Alves, A Bikfalvi Scientific Reports 7 (1), 10703, 2017 | 22 | 2017 |
| Microfluidic devices for the study of actin cytoskeleton in constricted environments: Evidence for podosome formation in endothelial cells exposed to a confined slit P Spuul, PY Chi, C Billottet, CF Chou, E Génot Methods 94, 65-74, 2016 | 21 | 2016 |
| Oligomerization state of CXCL4 chemokines regulates G protein-coupled receptor activation YP Chen, HL Wu, K Boye, CY Pan, YC Chen, N Pujol, CW Lin, LY Chiu, ... ACS Chemical Biology 12 (11), 2767-2778, 2017 | 17 | 2017 |
| Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation G Lorusso, CB Wyss, F Kuonen, N Vannini, C Billottet, N Duffey, R Pineau, ... Science translational medicine 14 (661), eaax8933, 2022 | 16 | 2022 |
| LRP-1 matricellular receptor involvement in triple negative breast cancer tumor angiogenesis O Campion, J Thevenard Devy, C Billottet, C Schneider, N Etique, ... Biomedicines 9 (10), 1430, 2021 | 9 | 2021 |
| Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from … B Malavaud, S Pedron, S Sordello, C Mazerolles, C Billottet, JP Thiery, ... Oncogene 23 (40), 6769-6778, 2004 | 3 | 2004 |
| La relation tumeur-stroma C Billottet, J Jouanneau Bulletin du cancer 95 (1), 51-56, 2008 | 1 | 2008 |
